Esperion Therapeutics Announces Removal of 240 mg Partial Clinical Hold for ETC-1002 by longitudeadmin | Jul 17, 2015 | Portfolio News
Rapid Micro Biosystems Completes $19 Million Senior Credit Facilities by longitudeadmin | Jul 8, 2015 | Portfolio News
Aimmune Therapeutics Files Registration Statement for Initial Public Offering by longitudeadmin | Jul 6, 2015 | Portfolio News
Collegium Expands Leadership Team With Vice President of Regulatory Affairs and Quality Assurance by longitudeadmin | Jul 1, 2015 | Portfolio News
